{
    "clinical_study": {
        "@rank": "154643", 
        "acronym": "COMET2", 
        "arm_group": [
            {
                "arm_group_label": "NDL-PDT/c-PDT", 
                "arm_group_type": "Experimental", 
                "description": "Metvix natural daylight photodynamic therapy and Metvix conventional photodynamic therapy"
            }, 
            {
                "arm_group_label": "NDL-PDT/placebo c-PDT", 
                "arm_group_type": "Experimental", 
                "description": "Metvix natural daylight photodynamic therapy and Metvix-placebo conventional photodynamic therapy"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will be conducted as a multi-centre, randomized, investigator-blind, active and\n      vehicle-controlled, intra-individual study.\n\n      The purpose of this study is to confirm that the Metvix NDL-PDT procedure is similar in\n      efficacy and less painful when compared to Metvix c-PDT procedure for the treatment of mild\n      and moderate AKs.\n\n      In addition this study will include a Metvix NDL-PDT arm versus Metvix vehicle cream c PDT\n      (Placebo) to assess the sensitivity of the trial."
        }, 
        "brief_title": "Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Actinic Keratoses", 
        "condition_browse": {
            "mesh_term": [
                "Keratosis", 
                "Keratosis, Actinic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of mild (Grade 1) and/or moderate (Grade 2) AKs on the face or the\n             scalp on treated areas\n\n          -  Subject with two symmetrical treated areas half scalps or two half faces excluding\n             ears, chin, bridge of the nose, eyelids and lips inside the vermillion border): no\n             more than a twofold difference in terms of total number of lesions between the two\n             TAs\n\n        Exclusion Criteria:\n\n          -  Subject with clinical diagnosis of at least one severe (Grade 3) AK on treated areas\n\n          -  Subject with pigmented AK on the treated areas\n\n          -  Immuno-compromised Subject for idiopathic, disease specific or therapeutic reasons\n\n          -  Subject with porphyria,"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01821391", 
            "org_study_id": "RD.03.SPR.29112"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "NDL-PDT/c-PDT", 
                    "NDL-PDT/placebo c-PDT"
                ], 
                "description": "Metvix natural daylight photodynamic therapy", 
                "intervention_name": "NDL-PDT", 
                "intervention_type": "Drug", 
                "other_name": "Metvix NDL-PDT"
            }, 
            {
                "arm_group_label": "NDL-PDT/c-PDT", 
                "description": "Metvix conventional photodynamic therapy", 
                "intervention_name": "c-PDT", 
                "intervention_type": "Drug", 
                "other_name": "Metvix c-PDT"
            }, 
            {
                "arm_group_label": "NDL-PDT/placebo c-PDT", 
                "description": "Metvix placebo conventional photodynamic therapy", 
                "intervention_name": "placebo c-PDT", 
                "intervention_type": "Drug", 
                "other_name": "Metvix placebo c-PDT"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methyl 5-aminolevulinate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "actinic keratoses", 
            "photodynamic therapy", 
            "natural daylight"
        ], 
        "lastchanged_date": "August 29, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France"
                    }, 
                    "name": "Investigative site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France"
                    }, 
                    "name": "Investigative site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aachen", 
                        "country": "Germany"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muenster", 
                        "country": "Germany"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Recklinghausen", 
                        "country": "Germany"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Assen", 
                        "country": "Netherlands"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maastricht", 
                        "country": "Netherlands"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Huesca", 
                        "country": "Spain"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain"
                    }, 
                    "name": "Investigative site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlskoga", 
                        "country": "Sweden"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norrk\u00f6ping", 
                        "country": "Sweden"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Netherlands", 
                "Spain", 
                "Sweden"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Multi-centre, Randomized, Investigator-blind, Intra-individual Active and Vehicle-controlled Study, Comparing Metvix Natural Daylight Photodynamic Therapy Versus Metvix Conventional Photodynamic Therapy in Subjects With Actinic Keratosis", 
        "overall_contact": {
            "email": "cyril.moulin@galderma.com", 
            "last_name": "Cyril Moulin, Dr", 
            "phone": "+33492383014"
        }, 
        "overall_official": [
            {
                "affiliation": "Hopital Saint Louis France", 
                "last_name": "Nicole Basset Seguin, PhD, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Ram\u00f3n y Cajal Spain", 
                "last_name": "Bibiana Perez Garcia, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Radboud University, Nijmegen Medical Center The Netherlands", 
                "last_name": "Rianne Gerritsen, PhD, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Klinik fur Dermatologie und Allergologie Germany", 
                "last_name": "Rolf-Markus Sziemies, PhD, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hudmottagningen Sweden", 
                "last_name": "Ingrid Synnerstad, PhD, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
                "Sweden: Medical Products Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "percent of lesions treated at baseline in complete response at week 12", 
            "measure": "lesion response", 
            "safety_issue": "No", 
            "time_frame": "week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01821391"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "subject self assessment of pain on a scale from 0 to 10.", 
            "measure": "pain score", 
            "safety_issue": "Yes", 
            "time_frame": "baseline"
        }, 
        "source": "Galderma", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Galderma", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}